Prudential PLC grew its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 41,143 shares of the medical research company’s stock after buying an additional 222 shares during the period. Prudential PLC’s […]
Schroder Investment Management Group grew its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 488,451 shares of the medical research company’s stock after buying an additional 79,919 shares […]
Westwood Holdings Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 10.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,189 shares of the medical research company’s stock after buying an additional 7,832 […]
Westwood Holdings Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 10.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,189 shares of the medical research company’s stock after buying an additional 7,832 […]
Epoch Investment Partners Inc. cut its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 47.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,870 shares of the medical research company’s stock after selling 62,821 shares during the period. […]